Form 4: Tandem Diabetes Care Executive Transfers Shares

Elizabeth Anne Gasser, EVP, Chief Strategy Officer at Tandem Diabetes Care Inc., transferred 7,160 shares of common stock to a family trust on June 2, 2026.

Summary

• Elizabeth Anne Gasser, Executive Vice President and Chief Strategy Officer of Tandem Diabetes Care Inc., reported a transaction on June 2, 2026.
• The transaction involved the transfer of 7,160 shares of common stock.
• These shares were transferred from Ms. Gasser's direct holdings to The Gasser Family Trust dated September 1, 2011.
• The transfer was made for no consideration.
• Following the transaction, Ms. Gasser beneficially owns 33,109 shares indirectly through the trust, of which she is a co-trustee.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine transfer of shares to a family trust rather than a sale or purchase that would indicate a change in the executive's investment thesis.

Positives

• The transfer of shares to a family trust is a common estate planning or wealth management activity and does not inherently indicate a negative outlook for the company.
• Ms. Gasser retains indirect beneficial ownership of the transferred shares, indicating continued interest in the company.

Negatives

• The transfer of shares, even to a trust, could be perceived by some investors as a reduction in direct holdings, although in this case, beneficial ownership remains.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from Tandem Diabetes Care, are standard disclosures for executive and director transactions. These filings provide transparency into insider holdings and activities, which can be a factor for investors monitoring corporate governance and insider sentiment.

Related Party Transactions

• Transfer of 7,160 shares of common stock from Elizabeth Anne Gasser to The Gasser Family Trust dated September 1, 2011, for no consideration. Ms. Gasser is a co-trustee of this trust.

Stakeholder Impact

• Shareholders: The transfer does not change the ultimate beneficial ownership of the shares, so there is no immediate impact on shareholder equity. It is a standard estate planning move.
• Management: Demonstrates typical executive actions related to personal financial planning.
• Trust Beneficiaries: The transfer aligns with the purpose of the family trust for managing family assets.

Key Dates

Keywords

Tandem Diabetes Care, TNDM, Form 4, Insider Transaction, Share Transfer, Beneficial Ownership, Family Trust, Elizabeth Anne Gasser, Executive Officer